查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2104638

生物資訊學人工智慧市場：按組件、應用、最終用戶、技術、國家和地區分類－全球產業分析、市場規模與佔有率及未來預測（2026-2033）

Artificial Intelligence in Bioinformatics Market, By Component, By Application, By End User, By Technology, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 299 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，生物資訊人工智慧 (AI) 市場規模將達到 37.805 億美元，並將在 2026 年至 2033 年期間以 24.6% 的複合年成長率成長。

在生物資訊學領域，人工智慧（AI）指的是利用機器學習、深度學習和自然語言處理等各種人工智慧技術來分析生物訊息，旨在加速基因組研究、提高蛋白質建模的預測準確性以及開發藥物和個人化療法。人工智慧驅動的生物資訊系統能夠比傳統分析方法更有效率地收集和分析大量的臨床、基因組、蛋白質組學和轉錄組學資料。人工智慧生物資訊系統的日益普及與基因組研究投入的增加以及藥物研發領域對相關解決方案日益成長的需求密切相關。此外，利用這些技術開展教育機構、生技公司和製藥公司之間的有效合作，將加速醫學診斷和生物標記的開發，以及個人化療法的研發。

生物資訊學人工智慧的市場動態

對基因組研究和人工智慧驅動的藥物發現的投資增加，正在加速市場成長。

次世代定序(NGS)、體學學和精準醫療產生的生物數據量日益成長，顯著推動了人工智慧在生物資訊領域的應用。隨著基因組學、蛋白質組學和臨床數據的數量和複雜性不斷增加，人工智慧驅動的分析工具在研究機構和製藥公司中得到越來越廣泛的應用，以便更好地管理這些數據。這些工具利用機器學習和深度學習演算法來幫助檢測疾病標記、預測蛋白質結構、闡明基因組變異，並簡化藥物發現流程和其他任務。此外，慢性病的日益增多和個人化醫療的普及也推動了基於人工智慧的生物資訊解決方案在臨床研究和診斷中的應用。同時，慢性病的日益增多和當前個人化醫療的趨勢也促使醫療專業人員轉向採用基於人工智慧的生物資訊方法。

例如，美國國立衛生研究院 (NIH) 透過「我們所有人」(All of Us) 研究計畫宣布發布其迄今為止規模最大的資料集。該資料集包含超過 74.7 萬名個體的數據，是全球最大的基因組和電子健康記錄 (EHR) 數據整合資料庫之一。它與超過 53.5 萬個全基因組序列和約 48.2 萬份電子健康記錄相連，為生物醫學研究提供了前所未有的基因組和臨床資訊。該計畫利用前沿的生物資訊學、基因測序和人工智慧驅動的分析技術，加速精準醫學研究，並加深我們對疾病風險和治療反應的理解。此類大規模計畫需要政府資助，用於開發人工智慧驅動的生物資訊平台，以處理複雜的生物醫學數據，並加速醫學領域的下一代研究。在這些大規模措施的背景下，高效管理複雜生物醫學數據的人工智慧驅動生物資訊平台的需求日益凸顯。

生物資訊學人工智慧市場：細分市場分析

全球生物資訊學人工智慧市場按組件、應用、最終用戶、技術和地區進行細分。

從應用角度來看，藥物發現和開發領域正在推動生物資訊學人工智慧市場的發展。這主要歸功於人工智慧演算法在標靶識別、分子建模、化合物篩檢、生物標記識別和臨床試驗最佳化等方面的日益普及。透過利用基於人工智慧的生物資訊技術，製藥公司可以輕鬆處理大量的基因組和蛋白質組數據，從而加速藥物發現進程。這些解決方案在製藥業，尤其是在個人化醫療、生技藥品和基因治療市場中的日益普及，正在推動市場成長。此外，這些服務在藥物研發領域，尤其是在個人化醫療、生物製藥和基因治療市場中的日益廣泛應用，也是市場發展的促進因素。例如，2024年5月，NVIDIA與IQVIA合作，利用NVIDIA的技術和IQVIA的醫療數據及分析能力，共同開發用於藥物發現和臨床開發的人工智慧解決方案。

從技術角度來看，機器學習（ML）持續推動市場發展。這是因為它能夠揭示基因組、轉錄組和蛋白質組數據中隱藏的模式，從而實現精準的疾病預測、突變分類和精準醫療研究。例如，在美國國家基因測序研究所（NHGRI），機器學習的應用範圍不斷擴展，涵蓋疾病基因識別、功能基因組學和精準醫療研究等大規模，用於分析大規模基因組定序計畫產生的基因組數據。隨著機器學習演算法在生物醫學研究中的應用日益廣泛，預計全球基於人工智慧的生物資訊解決方案的普及速度將進一步加快。

生物資訊學人工智慧市場—區域分析

北美是生物資訊學人工智慧市場的領先地區，憑藉其先進的生物技術基礎設施以及在藥物研發、基因測序和生命科學領域對人工智慧應用的大量投資，佔據了最大的市場佔有率。隨著對用於基因組資訊分析、生物標記發現、精準醫療配方和藥物研發的人工智慧生物資訊學工具的需求不斷成長，該市場持續發展。美國國立衛生研究院 (NIH) 下屬的國家醫學圖書館 (NLM) 的國家生物技術資訊中心 (NCBI) 提供各種免費的生物資訊資料庫和工具，包括 GenBank、BLAST 和 SRA。這些工具和資料庫被全球科學界廣泛用於人工智慧驅動的基因組數據分析、定序和計算生物學研究。在政府的支持下，這些生物資料庫被用於廣泛的生物數據分析，並在北美研究機構、製藥公司和醫療機構採用基於人工智慧的生物資訊解決方案方面發揮了關鍵作用。

歐洲也是一個重要的市場，其特點是基因組學、個人化醫療和生物醫學數據分析領域的投資不斷增加，合作研究計畫和數位健康計畫發揮著至關重要的作用。在學術界、製藥業和醫療保健領域，該地區正擴大使用融合人工智慧的生物資訊解決方案來改善疾病研究並加速治療方案的開發。例如，歐洲生物資訊研究所 (EBI) 是歐洲分子生物學實驗室 (EMBL) 的一部分，它提供開放取用的生物資料庫、相容人工智慧的生物資訊學工具以及先進的運算能力，用於歐洲蛋白質和基因組學的數據整合和研究。所有這些努力都在推動人工智慧驅動的生物資訊平台在歐洲的普及應用。

目錄

第1章：生物資訊學人工智慧市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：生物資訊學人工智慧的關鍵市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：生物資訊學人工智慧市場：產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景：概覽
  • 管理體制分析

第5章：生物資訊學人工智慧市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章 生物資訊學人工智慧市場趨勢

  • 生物資訊人工智慧市場佔有率分析（2025 年）
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章：生物資訊人工智慧市場：按組件分類

  • 概述
    • 基於細分市場的市場佔有率分析：按組件
    • 硬體
    • 軟體
      • 基於雲端的
      • 現場
    • 服務

第8章：生物資訊人工智慧市場：按應用領域分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • 藥物傳輸與開發
    • 基因組學和基因測序分析
    • 蛋白質體學和蛋白質結構預測
    • 精準醫療
    • 臨床診斷/疾病診斷
    • 其他

第9章：生物資訊學人工智慧市場：按最終用戶分類

  • 概述
    • 基於細分市場的市場佔有率分析：按最終用戶分類
    • 製藥和生物技術公司
    • 學術研究機構
    • 醫院和醫療保健機構
    • CRO（委外研發機構）
    • 診斷檢查室
    • 政府和公共衛生組織

第10章：生物資訊學人工智慧市場：按技術分類

  • 概述
    • 基於細分市場的市場佔有率分析：按技術分類
    • 機器學習（ML）
    • 深度學習
    • 自然語言處理（NLP）
    • 電腦視覺
    • 其他

第11章：生物資訊學人工智慧市場：按地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第12章：主要供應商分析：生物資訊人工智慧產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • Illumina, Inc.
    • Thermo Fisher Scientific Inc.
    • NVIDIA Corporation
    • QIAGEN NV
    • IBM Corporation
    • Microsoft Corporation
    • Google LLC
    • Oracle Corporation
    • SOPHiA GENETICS SA
    • DNAnexus, Inc.
    • Tempus AI, Inc.
    • BenevolentAI Limited
    • Insilico Medicine
    • Deep Genomics Inc.
    • BioSymetrics Inc.
    • Recursion Pharmaceuticals, Inc.
    • Schrodinger, Inc.
    • BenchSci
    • Atomwise, Inc.
    • PerkinElmer Inc.（Revvity）
    • Agilent Technologies, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Siemens Healthineers AG
    • Owkin, Inc.
    • PathAI, Inc.
    • BioAge Labs, Inc.
    • 其他

第13章：使用 AnalystView 進行綜合分析

簡介目錄
Product Code: ANV7108

Artificial Intelligence in Bioinformatics Market size was valued at US$ 3,780.5 Million in 2025, expanding at a CAGR of 24.6% from 2026 to 2033.

AI in bioinformatics implies the use of different techniques of artificial intelligence like machine learning, deep learning, natural language processing, etc., for the analysis of biological information for the purpose of speeding up genomics studies, improving predictions in protein modeling, and developing drugs and personalized therapies. Bioinformatics systems with the use of AI enable the collection and analysis of vast quantities of clinical, genomic, proteomic, and transcriptomic information much more effectively than conventional analyses. The growing popularity of AI bioinformatics systems is associated with investments made in genome research as well as an ever-increasing demand for the solutions used in drug development. In addition, the effective collaboration of educational institutions, biotechnology companies, and pharma corporations using the technologies will spur the development of medical diagnostics and markers and the creation of personalized treatments.

Artificial Intelligence in Bioinformatics Market- Market Dynamics

Growing Investments in Genomics Research and AI-Driven Drug Discovery Accelerating Market Growth

The increasing generation of biological data via Next-Generation Sequencing (NGS), omics science, and precision medicine is greatly propelling the adoption of Artificial Intelligence in Bioinformatics. The increasing amount and complexity of genomic, proteomic, and clinical data makes AI-enabled analytical tools increasingly popular among research institutes and pharma companies for proper management of the data. They help detect disease markers using machine learning and deep learning algorithms, predict protein structures, understand genomic variants, streamline the process of drug discovery and other operations. Besides, an increasing occurrence of chronic diseases along with the growing popularity of personalized medicine is increasing the adoption of AI-based solutions for bioinformatics in clinical research and diagnostics. Additionally, the increasing occurrences of chronic diseases, as well as the current trend of personalized medicine, make healthcare specialists move to the adoption of AI-based bioinformatics.

For instance, the United States National Institutes of Health (NIH) released a statement saying that the All of Us Research Program had made available the biggest data set to date, which consists of data of over 747,000 people and is among the world's biggest databases containing integrated genomic and electronic health record (EHR) data. The release contained more than 535,000 whole genome sequences paired with almost 482,000 electronic health records, providing an unprecedented amount of genomic and clinical information for biomedical research. The program will use cutting-edge bioinformatics, genomics sequencing and AI-powered analytical techniques to enhance the speed of precision medicine research and understanding of disease risk and response to treatment. These massive projects rely on the government to fund the development of AI-driven bioinformatics platforms that handle intricate biomedical data and facilitate next-generation research in healthcare. The need for AI-driven bioinformatics platforms that efficiently manage the complexities of biomedical data has been raised in the context of such large-scale initiatives.

Artificial Intelligence in Bioinformatics Market- Segmentation Analysis:

The Global Artificial Intelligence in Bioinformatics Market is segmented on the basis of Component, Application, End User, Technology, and Region.

From an application perspective, Drug Discovery & Development is dominating the Artificial Intelligence in Bioinformatics Market because of increasing adoption of AI algorithms for the purposes of target identification, molecular modeling, compound screening, biomarker identification, and optimization of clinical trials. Thanks to the use of bioinformatics technology based on Artificial Intelligence, companies working in the pharmaceutical industry are able to easily deal with massive amounts of genomic and proteomic data and facilitate the drug discovery process. The increasing adoption of these solutions within the pharmaceutical industry, particularly within the personalized medicine, biologics, and gene therapies markets, is driving the market. Increasing utilization of these services in pharmaceutical research, specifically in the personalized medicine, biologics and gene-based therapy markets, is yet another important market driver. For Example, in May 2024, NVIDIA partnered with IQVIA for the development of AI-based solutions for drug discovery and clinical development, using the technology of NVIDIA as well as healthcare data and analytics from IQVIA.

With Technology, Machine Learning (ML) is still leading the market as it discovers the hidden patterns in genomic, transcriptomic and proteomic data, which lead to accurate prediction of disease, variant classification and precision medicine research. For example, the National Human Genome Research Institute (NHGRI) is seeing the growing use of machine learning to analyze genome data produced by large-scale genome sequencing projects, in a range of disease gene identification, functional genomics and precision medicine research applications. As machine learning algorithms continue to be used more in biomedical research, their widespread adoption of AI-based bioinformatics solutions around the globe is likely to be further propelled.

Artificial Intelligence in Bioinformatics Market- Geographical Insights

North America is the major region holds largest market share in the Artificial Intelligence in Bioinformatics Market, due to the presence of advanced biotechnology infrastructure, pharmaceutical research, genome sequencing, and substantial investments in AI applications in the life sciences industry. With the rising requirement of AI-enabled bioinformatics tools for analyzing genomic information, finding biomarkers, formulating precision medicines and drug discovery, this market is growing. The National Center for Biotechnology Information (NCBI) is a component of the National Library of Medicine (NLM) at the National Institutes of Health (NIH) and offers various free bioinformatics databases and tools including GenBank, BLAST, and SRA. These tools and databases are being widely used across the world by the scientific community for genomic data analysis, sequence analysis and computational biology research through the use of AI. With the support of the government, the biological databases are being used for extensive analysis of biological data and have been instrumental in adopting AI-based bioinformatics solutions across research institutes, pharmaceutical companies and healthcare organizations in North America.

Europe is also a major market, marked by rising investments in genomics, personalized medicine and biomedical data analytics, with collaborative research projects and digital health programs playing a key part. In the academic world, pharmaceutical and healthcare sectors, the region is seeing increasing application of AI-infused bioinformatics solutions for better disease research and faster therapeutic advancements. For instance, the European Bioinformatics Institute (EBI), which is part of the European Molecular Biology Laboratory (EMBL), provides open access biological databases, bioinformatics tools compatible with AI, and advanced computational capabilities for data integration and research on proteins and genomics in Europe. All these initiatives are contributing to the adoption of bioinformatics platforms using AI technology in Europe.

Artificial Intelligence in Bioinformatics Market- Competitive Landscape:

The Artificial Intelligence in Bioinformatics Market is highly competitive, wherein the leading biotech and healthcare technologies, cloud computing analytics, and AI companies are aggressively involved in offering their AI-enabled solutions in the bioinformatics industry. Leading organizations in the market include Illumina, Inc., NVIDIA Corporation, Thermo Fisher Scientific Inc., QIAGEN N.V., IBM Corporation, Microsoft Corporation, Google LLC, Oracle Corporation, SOPHiA GENETICS, DNAnexus, Tempus AI, BenevolentAI, Insilico Medicine, BioSymetrics Inc., and Deep Genomics. To gain a competitive edge, firms are spending on AI-enabled genomic analysis tools, protein structure prediction tools, drug discovery software, and precision medicine solutions. Strategic partnerships and product innovations, acquisitions and cloud-based bioinformatics have enabled organizations to accelerate biomedical research, improve clinical decision-making and enable the analysis of large-scale bioinformatics and multi-omics data.

Recent Developments:

In February 2026, The U.S. Department of Agriculture's Animal and Plant Health Inspection Service has awarded Utah State University a $1.9 million contract to create new treatments, drugs and therapies for avian influenza. Associate Professor Rakesh Kaundal led the project using approaches of AI, machine learning and advanced bioinformatics.

In April 2025, Tempus AI entered into new multiyear strategic partnerships with AstraZeneca and Pathos AI for a multimodal foundation model in oncology. The partnership took advantage of Tempus' de-identified oncology information to provide biological and clinical insights, drug discovery and therapeutic development. Included in the agreements were $200 million in data licensing and model development fees.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ARTIFICIAL INTELLIGENCE IN BIOINFORMATICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • NVIDIA Corporation
  • QIAGEN N.V.
  • IBM Corporation
  • Microsoft Corporation
  • Google LLC
  • Oracle Corporation
  • SOPHiA GENETICS SA
  • DNAnexus, Inc.
  • Tempus AI, Inc.
  • BenevolentAI Limited
  • Insilico Medicine
  • Deep Genomics Inc.
  • BioSymetrics Inc.
  • Recursion Pharmaceuticals, Inc.
  • Schrodinger, Inc.
  • BenchSci
  • Atomwise, Inc.
  • PerkinElmer Inc. (Revvity)
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthineers AG
  • Owkin, Inc.
  • PathAI, Inc.
  • BioAge Labs, Inc.
  • Others

GLOBAL ARTIFICIAL INTELLIGENCE IN BIOINFORMATICS MARKET, BY COMPONENT- MARKET ANALYSIS, 2020 - 2033

  • Hardware
  • Software
  • Cloud-Based
  • On-Premise
  • Services

GLOBAL ARTIFICIAL INTELLIGENCE IN BIOINFORMATICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Drug Discovery and Development
  • Genomics and Gene Sequencing Analysis
  • Proteomics and Protein Structure Prediction
  • Precision Medicine
  • Clinical Diagnostics and Disease Diagnosis
  • Others

GLOBAL ARTIFICIAL INTELLIGENCE IN BIOINFORMATICS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Hospitals and Healthcare Providers
  • Contract Research Organizations (CROs)
  • Diagnostic Laboratories
  • Government and Public Health Organizations

GLOBAL ARTIFICIAL INTELLIGENCE IN BIOINFORMATICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033

  • Machine Learning (ML)
  • Deep Learning
  • Natural Language Processing (NLP)
  • Computer Vision
  • Others

GLOBAL ARTIFICIAL INTELLIGENCE IN BIOINFORMATICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Artificial Intelligence in Bioinformatics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
  • 2.2. Competitive Insights

3. Artificial Intelligence in Bioinformatics Key Market Trends

  • 3.1. Artificial Intelligence in Bioinformatics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Artificial Intelligence in Bioinformatics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Artificial Intelligence in Bioinformatics Market Opportunities
  • 3.4. Artificial Intelligence in Bioinformatics Market Future Trends

4. Artificial Intelligence in Bioinformatics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Artificial Intelligence in Bioinformatics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Artificial Intelligence in Bioinformatics Market Landscape

  • 6.1. Artificial Intelligence in Bioinformatics Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Artificial Intelligence in Bioinformatics Market - By Component

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2025 & 2033 (%)
    • 7.1.2. Hardware
    • 7.1.3. Software
      • 7.1.3.1. Cloud-Based
      • 7.1.3.2. On-Premise
    • 7.1.4. Services

8. Artificial Intelligence in Bioinformatics Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Drug Discovery and Development
    • 8.1.3. Genomics and Gene Sequencing Analysis
    • 8.1.4. Proteomics and Protein Structure Prediction
    • 8.1.5. Precision Medicine
    • 8.1.6. Clinical Diagnostics and Disease Diagnosis
    • 8.1.7. Others

9. Artificial Intelligence in Bioinformatics Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 9.1.2. Pharmaceutical and Biotechnology Companies
    • 9.1.3. Academic and Research Institutes
    • 9.1.4. Hospitals and Healthcare Providers
    • 9.1.5. Contract Research Organizations (CROs)
    • 9.1.6. Diagnostic Laboratories
    • 9.1.7. Government and Public Health Organizations

10. Artificial Intelligence in Bioinformatics Market - By Technology

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 10.1.2. Machine Learning (ML)
    • 10.1.3. Deep Learning
    • 10.1.4. Natural Language Processing (NLP)
    • 10.1.5. Computer Vision
    • 10.1.6. Others

11. Artificial Intelligence in Bioinformatics Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Artificial Intelligence in Bioinformatics Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Artificial Intelligence in Bioinformatics Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.17. Denmark
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.17.3. Poland Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.17.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.17.5. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.17.6. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.18. Rest of Europe
      • 11.3.18.1. Overview
      • 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.18.3. Rest of the Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.18.5. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.18.6. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Artificial Intelligence in Bioinformatics Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.16. Taiwan
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.16.3. Taiwan Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.16.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.16.5. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.16.6. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.17. Vietnam
      • 11.4.17.1. Overview
      • 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.17.3. Vietnam Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.17.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.17.5. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.17.6. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.18. Rest of APAC
      • 11.4.18.1. Overview
      • 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.18.3. Rest of APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.18.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.18.5. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.18.6. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Artificial Intelligence in Bioinformatics Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Artificial Intelligence in Bioinformatics Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.14. Iran
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.14.3. Iran Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.14.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.14.5. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.14.6. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.15. Qatar
      • 11.6.15.1. Overview
      • 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.15.3. Qatar Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.15.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.15.5. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.15.6. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.16. Rest of MEA
      • 11.6.16.1. Overview
      • 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.16.3. Rest of MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.16.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.16.5. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.16.6. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Artificial Intelligence in Bioinformatics Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Illumina, Inc.
    • 12.2.2. Thermo Fisher Scientific Inc.
    • 12.2.3. NVIDIA Corporation
    • 12.2.4. QIAGEN N.V.
    • 12.2.5. IBM Corporation
    • 12.2.6. Microsoft Corporation
    • 12.2.7. Google LLC
    • 12.2.8. Oracle Corporation
    • 12.2.9. SOPHiA GENETICS SA
    • 12.2.10. DNAnexus, Inc.
    • 12.2.11. Tempus AI, Inc.
    • 12.2.12. BenevolentAI Limited
    • 12.2.13. Insilico Medicine
    • 12.2.14. Deep Genomics Inc.
    • 12.2.15. BioSymetrics Inc.
    • 12.2.16. Recursion Pharmaceuticals, Inc.
    • 12.2.17. Schrodinger, Inc.
    • 12.2.18. BenchSci
    • 12.2.19. Atomwise, Inc.
    • 12.2.20. PerkinElmer Inc. (Revvity)
    • 12.2.21. Agilent Technologies, Inc.
    • 12.2.22. F. Hoffmann-La Roche Ltd.
    • 12.2.23. Siemens Healthineers AG
    • 12.2.24. Owkin, Inc.
    • 12.2.25. PathAI, Inc.
    • 12.2.26. BioAge Labs, Inc.
    • 12.2.27. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us